Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 6Genitourinary 3Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 2Other 1Dermatologic 1

Conditions

Prostatic Neoplasms 3Vitamin D Deficiency 1Fractures, Stress 1

Interventions

pembrolizumab 183Magnetic Resonance Spectroscopy 164Specimen Handling 135enzalutamide 126Nivolumab 125Gemcitabine 99Docetaxel 96Radiosurgery 92Prednisone 85Abiraterone Acetate 82Androgen Antagonists 81Radiotherapy 74apalutamide 69Cisplatin 65Ipilimumab 64darolutamide 63Biopsy 60abiraterone 58Carboplatin 57cabozantinib 55Leuprolide 53enfortumab vedotin 49Radiation 47Standard of Care 44Pluvicto 43atezolizumab 39Surveys and Questionnaires 39acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37olaparib 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Cholecalciferol × Genitourinary × 1 year × Clear all
NCT05045066 2026-03-02

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
220 enrolled
Genitourinary

Prostatic Neoplasms

NCT05838716 2026-01-15

ViPER

University of Rochester

Phase 3 Recruiting
240 enrolled
Genitourinary

Prostatic Neoplasms

NCT04621500 2025-07-04

VitD/RNA-seq

Medical University of South Carolina

Phase 2 Completed
60 enrolled 7 charts
Genitourinary

Prostatic Neoplasms, Vitamin D Deficiency, Fractures, Stress

Data powered by HemOnc (CC BY 4.0) Colophon âš¡